Home » Topics » BioWorld Science

BioWorld Science
RSS

Canadian researchers claim hPTH analogues for osteoporosis

Nov. 1, 1996

Lilly continues to investigate new agents for women's health

Nov. 1, 1996

Hybridon's VEGF-targeting antisense drugs for retinal neovascularization

Nov. 1, 1996

Hybridon's 1729 for multi-drug-resistant cancers

Nov. 1, 1996

New synthetic process for swainsonine should facilitate clinical testing

Nov. 1, 1996

Hybridon questions role of CAPL in cancer metastasis

Nov. 1, 1996

Low-toxicity antitumor agents described by Ajinomoto

Nov. 1, 1996

Antitumor organotin compounds claimed by Dutch company

Nov. 1, 1996

Peregrine seeks partners for development of vascular targeting agents

Nov. 1, 1996

Cell adhesion inhibitors reported by Sumitomo

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...